Partner Headlines - BMY

  1. Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF

    TalkMarkets
  2. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets
  3. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets
  4. Calithera Pharma In Focus Part 1 - Checkpoint Inhibition

    TalkMarkets
  5. AskSlim Market Week - 11/11/16

    TalkMarkets
  6. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets
  7. Trump Triumphs

    TalkMarkets
  8. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets
  9. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets
  10. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets
  11. Biotech Meltdown: Financial Metrics Offer Few Clues For What ...

    TalkMarkets
  12. Surviving Hillary - Surviving Donald: The Election Portfolio

    TalkMarkets
  13. Daily Update: Core Durable Goods Down 21 Straight Months

    TalkMarkets
  14. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  15. 5 Stocks To Watch Before The Market Opens Tomorrow (October 27, ...

    TalkMarkets
  16. Big Pharma’s Big Biotech Problem

    Dividend.com
  17. Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data

    TalkMarkets
  18. Earnings ESP

    TalkMarkets
  19. Rayno 2016 Life Science Portfolio Update

    TalkMarkets
  20. The Gap Inc. Leads 85 Stocks Going Ex-Dividend Next Week

    Dividend.com
  21. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to ...

    TalkMarkets
  22. Trending on Dividend.com: Bristol-Myers Disappoints and DHT Surprises, ...

    Dividend.com
  23. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily
  24. Amazon, Alphabet, Baidu, Ford, Celgene On Tap Thursday

    Investors Business Daily
  25. Investing Action Plan: Amazon, Alphabet, Baidu, Ford, Celgene

    Investors Business Daily
  26. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, ...

    Investors Business Daily
  27. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily
  28. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus
  29. Bristol-Myers Looks To A Promising Future

    Benzinga
  30. Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark ...

    Benzinga
  31. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD
  32. Earnings Recap For January 28

    Benzinga
  33. Bristol Myers Ticks Higher Following Q4 Beat, Encouraging Guidance

    Benzinga
  34. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus
  35. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga
  36. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga
  37. Benzinga's Top Downgrades

    Benzinga
  38. Bristol-Myers Squibb's Opdivo + Yervoy Receives Expanded FDA ...

    Benzinga
  39. Benzinga's Top Upgrades

    Benzinga
  40. Fast Money Traders Share Their Biotech Picks

    Benzinga
  41. Dual Therapeutics Announces Oncology Strategic Collaboration ...

    GuruFocus
  42. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD
  43. 3 Potential Blockbuster Drugs Launching in 2016

    IBD
  44. Lilly Guidance Misses Estimates On Lower Sales

    IBD
  45. Baxalta Cuts Cancer Deal As Shire Circles Nearer

    IBD
  46. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus
  47. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD
  48. Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare ...

    Benzinga
  49. Strategic Beta ETFs Among Year's Top Performers

    IBD
  50. Fast Money Picks For December 15

    Benzinga
  51. Signature Select Sells Stake in SPDR Gold Trust

    GuruFocus
  52. Bristol-Myers Squibb CompanyNew Longer-Term Data for Empliciti ...

    Benzinga
  53. Amgen Expands Work With Merck, Files Biosimilar In EU

    IBD
  54. Bristol-Myers Squibb's

    IBD
  55. Bristol-Myers Plans Projects

    IBD
  56. Bristol-Myers Looks Beyond Cancer To Build Portfolio

    IBD
  57. Bristol-Myers Squibb Announces U.S. Food and Drug Administration ...

    Benzinga
  58. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD
  59. Gilead Seen Staying Top Dog In HCV, But Merck Rising

    IBD
  60. BRISTOL-MYERS SQUIBB'S

    IBD
  61. Pamela Anderson And Hepatitis C: Which Drug Makers Are Working ...

    Benzinga
  62. Celgene Reports Mixed Q3 As Cancer Rivals Rise

    IBD
  63. Celgene Reports Mixed Q3 As Cancer Rivals Rise

    IBD
  64. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  65. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  66. Bristol-Myers Squibb

    IBD
  67. Gilead Outlook Disappoints

    IBD
  68. 4 Drugmakers Who Beat Q3 Estimates Tuesday

    IBD
  69. These Three Pharma Giants Just Crushed Earnings

    Benzinga
  70. Earnings Scheduled For October 27, 2015

    Benzinga
  71. Earnings Boom This Week: Big Pharma, E-Commerce Giant BABA And ...

    Benzinga
  72. Fed Meeting A Mid-Week Bump In Flurry Of Earnings News

    Benzinga
  73. Eli Lilly Q3 Earnings, Guidance Beat On Cost Control

    IBD
  74. Bristol-Myers Squibb Says NICE Recommends Daklinza for Treatment ...

    Benzinga
  75. Mid-Afternoon Market Update: Dow Jumps 175 Points; Garmin Shares ...

    Benzinga
  76. Mid-Day Market Update: Crude Oil Down 2%; Five Prime Therapeutics ...

    Benzinga
  77. Benzinga's Volume Movers

    Benzinga
  78. Mid-Morning Market Update: Markets Rise; Citigroup Profit Tops ...

    Benzinga
  79. Morning Market Gainers

    Benzinga
  80. Benzinga's Top #PreMarket Gainers

    Benzinga
  81. Bristol-Myers Squibb, Five Prime Therapeutics Announce Worldwide ...

    Benzinga
  82. Five Prime Therapeutics to Host Conference Call on Worldwide ...

    Benzinga
  83. Bristol-Myers drug approved

    IBD
  84. Bristol-Myers' Opdivo Gets Another Early Approval

    IBD
  85. Full SEC Comments Regarding Bristol-Myers Squibb FCPA Violations

    Benzinga
  86. Facebook, Netflix Top Goldman Sachs' 2016 Growth List

    IBD
  87. Alexion, Vertex Steal Mo Stanley's Eyes From Gilead

    IBD
  88. Fast Money Picks For October 2

    Benzinga
  89. Bristol-Myers Squibb Receives Approval from the U.S. Food and ...

    Benzinga
  90. 3 Big Drugs Likely To Hit The Market Soon

    IBD
  91. Bristol-Myers, J&J Upgraded On New Drug Prospects

    IBD
  92. Benzinga's Top Upgrades

    Benzinga
  93. Yahoo PT Cut Despite Alibaba; McDonald's Upgraded

    IBD
  94. Wall Street Ends Mixed After Seesaw Session

    FoxBusiness
  95. Opdivo (nivolumab) Demonstrates Long Term Survival Benefit in ...

    Benzinga
  96. Arrowhead Hits Target In Hepatitis B Drug Trial

    IBD
  97. Fast Money Picks For September 21

    Benzinga
  98. Make The World A Better Place With...Stock Picks?

    Benzinga
  99. Jim Cramer Shares His Thoughts On Home Depot, Bristol-Myers Squibb, ...

    Benzinga
  100. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
Trading Center